In a scandal that's rocking the nation 😱, Kobayashi Pharmaceutical's red yeast rice products are under fire 🔥! An investigation by Teikoku Databank reveals that up to 33,000 enterprises in Japan might be affected by health issues linked to these products.
It all started when the Osaka-based pharmaceutical giant supplied red yeast rice raw materials to 225 companies. Some of these materials were sold directly, while others were processed and resold, potentially impacting a staggering number of businesses across the country.
Among those affected, food and beverage retailers take the biggest hit with 5,582 enterprises 😔. But it doesn't stop there! The ripple effect extends to 5,171 other retail businesses, 3,884 medical enterprises, and 3,115 restaurants.
Kobayashi Pharmaceutical has already recalled multiple products, including their popular \"Beni-koji choleste-help\" supplement. Marketed as a cholesterol reducer, this supplement contains red yeast rice, or \"beni-koji,\" which has been potentially linked to adverse health events. As of Monday, there have been five reported deaths and about 166 hospitalizations connected to these products. Our hearts go out to those affected ❤️.
This scandal not only raises concerns about product safety but also highlights the interconnectedness of industries in Japan 🇯🇵. Stay tuned for more updates on how this unfolds!
Reference(s):
Kobayashi scandal may impact 33,000 firms in Japan: investigation
cgtn.com
